Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.74 USD | -5.67% | -5.60% | -10.38% |
May. 09 | Earnings Flash (ACLX) ARCELLX Posts Q1 Revenue $39.3M | MT |
May. 09 | Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program | CI |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 105M | Capitalization | 2.65B |
---|---|---|---|---|---|
Net income 2024 * | -97M | Net income 2025 * | -121M | EV / Sales 2024 * | 15.6 x |
Net cash position 2024 * | 732M | Net cash position 2025 * | 548M | EV / Sales 2025 * | 20 x |
P/E ratio 2024 * |
-23.6
x | P/E ratio 2025 * |
-25.3
x | Employees | 130 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.61% |
1 day | -5.67% | ||
1 week | -5.60% | ||
Current month | -0.56% | ||
1 month | -15.81% | ||
3 months | -23.35% | ||
6 months | +9.29% | ||
Current year | -10.38% |
Managers | Title | Age | Since |
---|---|---|---|
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21-01-21 |
Michelle Gilson
DFI | Director of Finance/CFO | 32 | 22-05-22 |
David Tice
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 20-07-31 |
Ali Behbahani
BRD | Director/Board Member | 47 | 15-01-31 |
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21-01-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | -.--% | - | |
0.01% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 49.74 | -5.67% | 925,475 |
24-05-09 | 52.73 | +0.92% | 377,239 |
24-05-08 | 52.25 | -0.32% | 545,473 |
24-05-07 | 52.42 | -0.47% | 311,293 |
24-05-06 | 52.67 | -0.04% | 261,552 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.38% | 2.65B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ACLX Stock